Windtree Therapeutics, Inc.
WINT
$0.5571
-$0.011-1.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -246.19% | 200.65% | 77.14% | -217.66% | 298.27% |
| Total Depreciation and Amortization | 104.49% | -347.71% | -47.06% | 1,276.19% | 107.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 101.86% | -361.57% | -119.63% | 153.56% | -1,577.60% |
| Change in Net Operating Assets | 84.30% | 134.63% | -236.77% | 43.53% | 32.08% |
| Cash from Operations | 34.68% | 42.82% | -177.04% | 21.07% | 17.38% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -100.00% | -87.97% | -- | -- |
| Total Debt Repaid | -49.55% | 75.92% | -- | 100.00% | 0.43% |
| Issuance of Common Stock | -50.37% | -44.38% | -- | -100.00% | 81.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 53.06% | -21.49% | -- | -- | -- |
| Total Dividends Paid | 70.97% | 10.66% | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 247.06% | 32.00% | -- |
| Cash from Financing | -43.08% | -54.42% | 335.45% | 54.16% | 98.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.31% | -204.83% | 166.80% | 61.11% | 37.20% |